Huperzine for Cognitive and Functional Impairment in Schizophrenia
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
Huperzine is a natural plant product with procognitive properties in patients with
Alzheimer's disease. Cognitive difficulties hamper functioning in schizophrenia as well. The
present study will investigate whether huperzine improves cognition and functioning in
patients with schizophrenia.